Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.

Rosell K, Hymnelius K, Swartling C.

Acta Derm Venereol. 2013 May;93(3):335-9. doi: 10.2340/00015555-1464.

2.

Treatment of hyperhidrosis with botulinum toxin.

Doft MA, Hardy KL, Ascherman JA.

Aesthet Surg J. 2012 Feb;32(2):238-44. doi: 10.1177/1090820X11434506. Review.

PMID:
22328694
3.

Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study.

Basciani M, Di Rienzo F, Bizzarrini M, Zanchi M, Copetti M, Intiso D.

Arch Dermatol Res. 2014 Jul;306(5):497-503. doi: 10.1007/s00403-014-1449-7. Epub 2014 Feb 14.

PMID:
24522897
4.

Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.

Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J.

Int J Dermatol. 2005 May;44(5):418-24.

PMID:
15869543
5.

[Botulinum toxin in the treatment of focal hyperhidrosis].

Schnider P, Moraru E, Kittler H, Voller B, Kranz G, Auff E.

Wien Klin Wochenschr. 2001;113 Suppl 4:36-41. Review. German.

PMID:
15506051
6.

[Treated patients in survey: High satisfaction with botulinum toxin in palmar hyperhidrosis].

Deebaj R, Emtestam L, Lundeberg L, Brandin Samuelsson K, Girnita A.

Lakartidningen. 2015 Jan 27;112. pii: C6RC. Swedish.

PMID:
25625725
7.

Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.

Campanati A, Penna L, Guzzo T, Menotta L, Silvestri B, Lagalla G, Gesuita R, Offidani A.

Clin Ther. 2003 Jan;25(1):298-308.

PMID:
12637128
8.

A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.

Wolosker N, de Campos JR, Kauffman P, Puech-Leão P.

J Vasc Surg. 2012 Jun;55(6):1696-700. doi: 10.1016/j.jvs.2011.12.039. Epub 2012 Feb 16.

9.

Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.

Baumann L, Slezinger A, Halem M, Vujevich J, Mallin K, Charles C, Martin LK, Black L, Bryde J.

Dermatol Surg. 2005 Mar;31(3):263-70.

PMID:
15841624
10.
11.

Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.

Frasson E, Brigo F, Acler M, Didonè G, Vicentini S, Bertolasi L.

Arch Dermatol. 2011 Jan;147(1):122-3. doi: 10.1001/archdermatol.2010.408. No abstract available.

PMID:
21242408
12.

Botulinum toxin type B: a new therapy for axillary hyperhidrosis.

Nelson L, Bachoo P, Holmes J.

Br J Plast Surg. 2005 Mar;58(2):228-32.

PMID:
15710119
13.

The place of botulinum toxin type A in the treatment of focal hyperhidrosis.

Lowe N, Campanati A, Bodokh I, Cliff S, Jaen P, Kreyden O, Naumann M, Offidani A, Vadoud J, Hamm H.

Br J Dermatol. 2004 Dec;151(6):1115-22. Review.

PMID:
15606505
14.

Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.

Swartling C, Naver H, Lindberg M.

Eur J Neurol. 2001 May;8(3):247-52.

PMID:
11328333
15.

Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?

Kouris A, Vavouli C, Markantoni V, Kontochristopoulos G.

J Drugs Dermatol. 2014 Nov;13(11):1315-6.

PMID:
25607695
16.

No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.

Krogstad AL, Skymne A, Pegenius G, Elam M, Wallin BG.

Br J Dermatol. 2005 Feb;152(2):329-33.

PMID:
15727647
17.

Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.

Schnider P, Moraru E, Kittler H, Binder M, Kranz G, Voller B, Auff E.

Br J Dermatol. 2001 Aug;145(2):289-93.

PMID:
11531794
18.

Evaluation of objective methods to diagnose palmar hyperhidrosis and monitor effects of botulinum toxin treatment.

Krogstad AL, Skymne BS, Göran Pegenius BS, Elam M, Wallin BG.

Clin Neurophysiol. 2004 Aug;115(8):1909-16.

PMID:
15261869
19.

Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.

Naver H, Swartling C, Aquilonius SM.

Eur J Neurol. 2000 Jan;7(1):55-62.

PMID:
10809915
20.

Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.

Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, Ganzetti G, Offidani A.

J Eur Acad Dermatol Venereol. 2011 Aug;25(8):917-21. doi: 10.1111/j.1468-3083.2010.03880.x. Epub 2010 Nov 4.

PMID:
21054569

Supplemental Content

Support Center